 |
인쇄하기
취소
|
Positive list system faces backlash
The Health Insurance Review & Assessment Service will have to re-evaluate the economic effectiveness of antihyperlipemic agents, as 20 pharmaceutical firms – Pfizer Korea, AstraZeneca Korea and Novartis Korea – asked the HIRA to re-assess its assessment.
HIRA officials said that a total of 61 drug makers submitted opposition to the HIRA.
It will take 90 days for the HIRA to re-evaluate op...
HIRA officials said that a total of 61 drug makers submitted opposition to the HIRA.
It will take 90 days for the HIRA to re-evaluate op...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.